Intervention
HRS-7535 Tablets
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 3 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
3 shownA Study to Evaluate the Drug Interactions of HRS-7535 With Acetaminophen, Digoxin, Rosuvastatin, and Omeprazole in Obese or Overweight SubjectsNCT07269756 · 2025-12-07
COMPLETEDA Trial of HRS-7535 Tablets in Subjects With Overweight or ObesityNCT06904105 · 2025-04-10
COMPLETEDPharmacokinetic and Safety Studies of HRS-7535 in Subjects With Moderate Renal Insufficiency and Healthy SubjectsNCT06132204 · 2023-12-21
COMPLETEDCommon conditions
Leading sponsors
Trial status mix
COMPLETED3
Phase mix
PHASE12
PHASE31
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.